Pro Share Advisors LLC Moderna, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 429,298 shares of MRNA stock, worth $20.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

429,298

Previous 401,548 6.91%

Holding current value

$20.4 Million

Previous $47.7 Million 39.83%

% of portfolio

0.07%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $1.77 Million - $3.47 Million	27,750 Added 6.91%	429,298 $28.7 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $4.36 Million - $7.18 Million	-43,073 Reduced 9.69%	401,548 $47.7 Million
Q1 2024 May 08, 2024	BUY	$85.37 - $115.44 $6.66 Million - $9.01 Million	78,017 Added 21.28%	444,621 $47.4 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $4.31 Million - $6.47 Million	-61,975 Reduced 14.46%	366,604 $36.5 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $5.2 Million - $6.83 Million	53,937 Added 14.4%	428,579 $44.3 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $3.47 Million - $4.7 Million	-29,289 Reduced 7.25%	374,642 $45.5 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $5.07 Million - $7.36 Million	37,368 Added 10.19%	403,931 $62 Million
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $6.15 Million - $10.9 Million	-51,985 Reduced 12.42%	366,563 $65.8 Million
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $9.8 Million - $16.1 Million	-83,002 Reduced 16.55%	418,548 $49.5 Million
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $30.5 Million - $46 Million	-260,438 Reduced 34.18%	501,550 $71.6 Million
Q1 2022 May 10, 2022	SELL	$126.46 - $235.05 $3.62 Million - $6.73 Million	-28,621 Reduced 3.62%	761,988 $131 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $55.6 Million - $90.7 Million	246,204 Added 45.22%	790,609 $201 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $19.5 Million - $42.5 Million	87,676 Added 19.2%	544,405 $210 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $1.18 Million - $2.14 Million	-9,111 Reduced 1.96%	456,729 $107 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $7.72 Million - $13.1 Million	70,703 Added 17.89%	465,840 $61 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $3.35 Million - $8.66 Million	50,961 Added 14.81%	395,137 $41.3 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $15.1 Million - $26.3 Million	277,285 Added 414.53%	344,176 $24.4 Million
Q2 2020 Aug 03, 2020	BUY	$29.67 - $80.0 $512,519 - $1.38 Million	17,274 Added 34.81%	66,891 $4.3 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $486,887 - $864,786	-27,384 Reduced 35.56%	49,617 $1.49 Million
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $1.07 Million - $1.64 Million	77,001 New	77,001 $1.51 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $18.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Moderna, Inc. Transaction History